Clarus (CLAR) director granted 20,000 stock options at $3.11 strike

Rhea-AI Filing Summary

Clarus Corp director Mark Besca received a grant of stock options covering 20,000 shares of common stock. The options were awarded at an exercise price of $3.11 per share and were granted at no upfront cost. They expire on May 28, 2036 and were issued under the company’s Amended and Restated 2015 Stock Incentive Plan.

According to the vesting schedule, options for 5,000 shares will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. After this grant, Besca holds options to purchase 20,000 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Besca Mark

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to purchase)	20,000	$0.00	--

Holdings After Transaction: Stock Option (right to purchase) — 20,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 20,000 options Exercise price: $3.11 per share Expiration date: May 28, 2036 +2 more

5 metrics

Option grant size 20,000 options Stock options to purchase Clarus common stock granted to director

Exercise price $3.11 per share Conversion or exercise price for the stock options

Expiration date May 28, 2036 Options expire on this date if not exercised

Post-grant option holdings 20,000 options Total options held by Mark Besca following this grant

Vesting installments 5,000 options each date Vest on June 30, 2026; Sept 30, 2026; Dec 31, 2026; Mar 31, 2027

Key Terms

Stock Option (right to purchase), Amended and Restated 2015 Stock Incentive Plan, vesting, exercise price

4 terms

Stock Option (right to purchase) financial

"Security title is listed as "Stock Option (right to purchase)" for this grant."

Amended and Restated 2015 Stock Incentive Plan financial

"The option was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan."

vesting financial

"Options to purchase 5,000 shares will vest and become exercisable on four specified dates."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"The conversion or exercise price for the stock options is $3.11 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Besca Mark

(Last) (First) (Middle)

C/O CLARUS CORPORATION

2084 EAST 3900 SOUTH

(Street)

SALT LAKE UTAH 84124

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clarus Corp [ CLAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to purchase)	$3.11	05/28/2026		A		20,000		(1)	05/28/2036	Common Stock	20,000	$0	20,000	D

Explanation of Responses:

1. The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

	/s/ Mark Besca	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clarus Corp (CLAR) director Mark Besca report in this Form 4?

Mark Besca reported receiving a grant of stock options for 20,000 Clarus Corp common shares. These options were awarded as a compensation-related grant, not an open-market purchase, and give him the right to buy shares at a fixed exercise price.

How many Clarus Corp (CLAR) shares are covered by Mark Besca’s new stock options?

The new option grant covers 20,000 shares of Clarus Corp common stock. These options give him the right to purchase that number of shares if he chooses to exercise them once they vest and before they expire.

What is the exercise price and expiration date of Mark Besca’s Clarus (CLAR) options?

The options have an exercise price of $3.11 per share and expire on May 28, 2036. This means Besca can buy shares at $3.11, if vested, any time before the expiration date.

How do Mark Besca’s Clarus Corp (CLAR) stock options vest over time?

The 20,000 options vest in four equal installments of 5,000 shares each. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, after which vested portions become exercisable.

Is Mark Besca’s Clarus (CLAR) Form 4 transaction an open-market buy or sale?

It is not an open-market buy or sale. The Form 4 reports a grant or award of stock options as compensation. No shares were bought or sold in the market; he received derivative rights to purchase shares in the future.